Robert A Abrams, DPM
Podiatry · West Covina
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 54 years
- New York College of Podiatric Medicine, 1972
Offices
1 location
Looking this up.
Hospitals listed: Emanate Health Inter-Community Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Abrams’s office to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Emanate Health Inter-Community HospitalCovina, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Emanate Health, which runs 3 hospitalsPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Emanate Health Inter-Community Hospital
Behind the star rating — Deaths: 0 better, 6 the same, 2 worse of 8 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.4 (0.39 to 2.4) · 990 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.53 to 1.18) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 198.56 (145.92 to 251.21) · 69 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.9 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 99 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.8 · 107 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.1 · 279 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.2 · 665 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.3 · 389 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.1 · 3,599 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 6,844 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.42) · 6,958 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.21 (0.98 to 5.43) · 1,118 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.46 (0 to 3.08) · 379 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.05 (0.53 to 3.58) · 1,140 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.68 (1.69 to 15.67) · 450 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.07 (1.14 to 9) · 397 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.18 to 3.17) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 0.97) · 5,698 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 213 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.578 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.853 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.438 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.205 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.1 · 352 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.7 · 631 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -2 · 136 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 1.5 · 336 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -2.2 · 731 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 1,007 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.5 to 8) · 53 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (8.8 to 16.5) · 53 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.4 · 191 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.7 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 188 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.6) · 113 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 106 cases | No different | Jan 2024 – Dec 2024 |
What patients said (924 patients answered, 12% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 70% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 81% |
| Yes, staff "did" give patients information about help after discharge | 77% |
| Doctors "always" explained things so they could understand | 64% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 77% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 66% |
| Nurses "always" listened carefully | 67% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$44,005
Medicare paid this office $44,005 for 170 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of fingernails or toenails, 1-5 nails | 124 | $8,629 | $28 |
| Short return visit (20+ min) | 70 | $8,147 | $77 |
| Removal of noncancer thickened skin growth, 2-4 growths | 39 | $4,451 | $65 |
| New patient visit (30+ min) | 42 | $3,696 | $88 |
| Short return visit | 53 | $3,470 | $46 |
See all 8 services
| Removal of fingernails or toenails, 1-5 nails | 124 | $8,629 | $28 |
| Short return visit (20+ min) | 70 | $8,147 | $77 |
| Removal of noncancer thickened skin growth, 2-4 growths | 39 | $4,451 | $65 |
| New patient visit (30+ min) | 42 | $3,696 | $88 |
| Short return visit | 53 | $3,470 | $46 |
| Trimming of dystrophic nails, any number | 65 | $2,720 | $19 |
| Removal of noncancer thickened skin growth, 1 growth | 15 | $1,128 | $47 |
| X-ray of foot, minimum of 3 views | 20 | $991 | $31 |
Procedures Medicare counted
| Removal of nail tissue | 1027 | More than 92% of doctors who do this |
| Removal of skin lesions | 1-10 | None |
| Removal of tissue | 207 | More than 92% of doctors who do this |
| Removal or shaving of skin growth | 537 | More than 96% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of fingernails or toenails, 1-5 nails | 489 | 328 | 264 | 333 | 305 | 303 |
| Removal of noncancer thickened skin growth, 2-4 growths | 144 | 87 | 91 | 89 | 76 | 68 |
| Removal of noncancer thickened skin growth, more than 4 growths | 34 | 21 | 28 | 28 | – | – |
| Removal of inflamed or infected skin, up to 10% of body surface | 23 | 18 | 17 | – | – | – |
| Injection into tendon or ligament | 23 | 19 | – | – | – | – |
| Removal of noncancer thickened skin growth, 1 growth | – | – | – | – | – | 24 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
170 Original Medicare patients in 2024. Average age 73 · Under 65 15% · 85 and older 15% · Women 53% · Also on Medicaid 58% · Health risk score 1.87. Above the middle of the specialty; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 75% · Diabetes 66% · Chronic kidney disease 39% · Coronary heart disease 35% · Heart failure 25% · Depression 18% · Cancer 16% · COPD 16% · Atrial fibrillation 15% · Dementia 8% · Stroke 6%.
The office billed $69,986, Medicare allowed $56,574 and paid $44,005; for 912 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 170 | 912 | 73 | 1.87 | $69,986 | $44,005 |
| 2023 | 176 | 834 | 73 | 1.86 | $55,942 | $35,437 |
| 2022 | 191 | 1,006 | 72 | 1.76 | $62,440 | $38,105 |
| 2021 | 180 | 981 | 73 | 1.96 | $64,650 | $39,761 |
| 2020 | 216 | 1,160 | 73 | 2.45 | $94,930 | $54,378 |
| 2019 | 264 | 1,588 | 74 | 2.42 | $131,095 | $74,703 |
| 2018 | 287 | 2,546 | 73 | 2.58 | $336,015 | $177,286 |
| 2017 | 298 | 2,116 | 72 | 2.41 | $228,545 | $118,714 |
| 2016 | 281 | 1,501 | 72 | 2.37 | $103,495 | $59,631 |
| 2015 | 303 | 1,426 | 72 | 2.62 | $92,285 | $52,457 |
| 2014 | 386 | 1,942 | 73 | 2.28 | $122,895 | $66,787 |
| 2013 | 428 | 2,349 | 72 | 2.28 | $147,755 | $79,736 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Removal of fingernails or toenails, 1-5 nails | 129 | $8,888 | $29 |
| Short return visit (20+ min) | 73 | $6,156 | $56 |
| New patient visit (30+ min) | 38 | $3,402 | $90 |
| Removal of noncancer thickened skin growth, 2-4 growths | 47 | $3,175 | $42 |
| Trimming of dystrophic nails, any number | 66 | $2,384 | $19 |
| Short return visit | 45 | $2,352 | $39 |
2022: 8 services
| Removal of fingernails or toenails, 1-5 nails | 139 | $9,622 | $29 |
| Short return visit (20+ min) | 85 | $6,462 | $52 |
| Trimming of dystrophic nails, any number | 85 | $3,804 | $18 |
| New patient visit (30+ min) | 38 | $3,708 | $98 |
| Removal of noncancer thickened skin growth, 2-4 growths | 49 | $3,520 | $40 |
| Short return visit | 52 | $2,933 | $39 |
| Removal of noncancer thickened skin growth, more than 4 growths | 14 | $1,328 | $47 |
| X-ray of foot, minimum of 3 views | 17 | $710 | $32 |
2021: 10 services
| Removal of fingernails or toenails, 1-5 nails | 121 | $7,569 | $29 |
| Short return visit (20+ min) | 85 | $7,284 | $51 |
| New patient visit (30+ min) | 52 | $5,078 | $98 |
| Short return visit | 65 | $3,559 | $39 |
| Removal of noncancer thickened skin growth, 2-4 growths | 48 | $3,521 | $39 |
| Trimming of dystrophic nails, any number | 67 | $2,945 | $18 |
| Removal of tissue from wound, 20.0 sq cm or less | 11 | $2,887 | $90 |
| Removal of noncancer thickened skin growth, more than 4 growths | 16 | $1,296 | $46 |
| X-ray of foot, minimum of 3 views | 18 | $927 | $32 |
| Removal of inflamed or infected skin, up to 10% of body surface | 11 | $896 | $53 |
2020: 13 services
| Removal of fingernails or toenails, 1-5 nails | 152 | $9,282 | $28 |
| Short return visit (20+ min) | 80 | $6,773 | $50 |
| New patient visit (30+ min) | 47 | $4,028 | $86 |
| Removal of tissue from wound, 20.0 sq cm or less | 11 | $3,377 | $89 |
| Removal of noncancer thickened skin growth, 2-4 growths | 52 | $3,373 | $39 |
| Trimming of dystrophic nails, any number | 78 | $3,262 | $19 |
| Short return visit | 56 | $2,966 | $39 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,318 | $120 |
| Removal of noncancer thickened skin growth, more than 4 growths | 11 | $999 | $48 |
| Removal of inflamed or infected skin, up to 10% of body surface | 11 | $927 | $51 |
| Injection into tendon or ligament | 12 | $879 | $46 |
| X-ray of foot, minimum of 3 views | 17 | $874 | $30 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 14 | $115 | None |
2019: 13 services
| Removal of fingernails or toenails, 1-5 nails | 196 | $13,751 | $29 |
| Short return visit (20+ min) | 86 | $6,868 | $50 |
| New patient visit (30+ min) | 61 | $5,736 | $94 |
| Removal of noncancer thickened skin growth, 2-4 growths | 77 | $5,604 | $39 |
| Trimming of dystrophic nails, any number | 102 | $4,195 | $19 |
| Short return visit | 69 | $3,268 | $38 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $2,235 | $118 |
| Removal of noncancer thickened skin growth, more than 4 growths | 19 | $1,600 | $47 |
| X-ray of foot, minimum of 3 views | 32 | $1,277 | $28 |
| Removal of inflamed or infected skin, up to 10% of body surface | 16 | $1,134 | $49 |
| Injection into tendon or ligament | 17 | $1,017 | $44 |
| Removal of fingernails or toenails, 1-5 nails | 17 | $213 | $13 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 19 | $140 | None |
2018: 13 services
| Removal of fingernails or toenails, 1-5 nails | 223 | $14,645 | $27 |
| Short return visit (20+ min) | 110 | $9,708 | $50 |
| New patient visit (30+ min) | 81 | $6,849 | $85 |
| Removal of noncancer thickened skin growth, 2-4 growths | 98 | $6,765 | $37 |
| Removal of skin and tissue, 20.0 sq cm or less | 16 | $5,283 | $100 |
| Trimming of dystrophic nails, any number | 126 | $4,868 | $17 |
| Short return visit | 53 | $2,340 | $36 |
| Removal of noncancer thickened skin growth, more than 4 growths | 22 | $2,206 | $45 |
| Removal of tissue from wound, 20.0 sq cm or less | 14 | $1,946 | $72 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,397 | $116 |
| X-ray of foot, minimum of 3 views | 26 | $828 | $24 |
| Injection into tendon or ligament | 11 | $456 | $41 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 13 | $73 | None |
2017: 17 services
| Removal of fingernails or toenails, 1-5 nails | 231 | $13,718 | $26 |
| Short return visit (20+ min) | 99 | $7,491 | $49 |
| New patient visit (30+ min) | 78 | $6,587 | $84 |
| Removal of noncancer thickened skin growth, 2-4 growths | 89 | $5,686 | $37 |
| Trimming of dystrophic nails, any number | 131 | $4,646 | $15 |
| Removal of skin and tissue, 20.0 sq cm or less | 11 | $3,386 | $97 |
| Removal of noncancer thickened skin growth, more than 4 growths | 27 | $2,722 | $44 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $2,420 | $115 |
| Short return visit | 43 | $1,789 | $35 |
| Removal of tissue from wound, 20.0 sq cm or less | 13 | $1,649 | $63 |
| X-ray of foot, minimum of 3 views | 39 | $1,268 | $24 |
| Removal of inflamed or infected skin, up to 10% of body surface | 13 | $806 | $45 |
| Injection into tendon or ligament | 14 | $641 | $40 |
| Removal of fingernails or toenails, 6 or more nails | 13 | $626 | $37 |
| Removal of fingernails or toenails, 1-5 nails | 19 | $222 | $12 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 17 | $114 | None |
| Trimming of dystrophic nails, any number | 13 | $61 | $5 |
2016: 15 services
| Removal of fingernails or toenails, 1-5 nails | 208 | $12,154 | $27 |
| New patient visit (30+ min) | 93 | $8,258 | $89 |
| Short return visit (20+ min) | 94 | $7,899 | $50 |
| Removal of skin and tissue, 20.0 sq cm or less | 22 | $7,750 | $99 |
| Removal of noncancer thickened skin growth, 2-4 growths | 87 | $6,365 | $39 |
| Trimming of dystrophic nails, any number | 114 | $3,727 | $16 |
| Short return visit | 45 | $2,186 | $36 |
| Removal of noncancer thickened skin growth, more than 4 growths | 24 | $2,170 | $46 |
| X-ray of foot, minimum of 3 views | 30 | $1,136 | $25 |
| Removal of tissue from wound, 20.0 sq cm or less | 12 | $1,099 | $65 |
| Removal of inflamed or infected skin, up to 10% of body surface | 19 | $1,012 | $46 |
| Injection into tendon or ligament | 12 | $740 | $46 |
| Removal of fingernails or toenails, 6 or more nails | 16 | $567 | $35 |
| X-ray of foot, 2 views | 11 | $289 | $22 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 11 | $70 | None |
2015: 14 services
| Removal of fingernails or toenails, 1-5 nails | 221 | $12,319 | $27 |
| Removal of noncancer thickened skin growth, 2-4 growths | 111 | $7,427 | $39 |
| New patient visit (30+ min) | 81 | $7,114 | $88 |
| Short return visit (20+ min) | 97 | $6,703 | $50 |
| Removal of skin and tissue, 20.0 sq cm or less | 14 | $2,737 | $101 |
| Trimming of fingernails or toenails | 115 | $2,078 | $10 |
| Removal of noncancer thickened skin growth, more than 4 growths | 28 | $1,976 | $47 |
| Short return visit | 38 | $1,605 | $37 |
| Injection into tendon or ligament | 16 | $1,156 | $46 |
| X-ray of foot, minimum of 3 views | 30 | $1,054 | $25 |
| Removal of inflamed or infected skin, up to 10% of body surface | 13 | $747 | $47 |
| Removal of fingernails or toenails, 6 or more nails | 17 | $689 | $38 |
| Removal of noncancer thickened skin growth, 1 growth | 17 | $638 | $35 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 17 | $120 | None |
2014: 15 services
| Removal of fingernails or toenails, 1-5 nails | 251 | $14,677 | $28 |
| Removal of noncancer thickened skin growth, 2-4 growths | 140 | $10,387 | $39 |
| Short return visit (20+ min) | 110 | $8,247 | $50 |
| New patient visit (30+ min) | 74 | $6,624 | $90 |
| Removal of tissue from wound, 20.0 sq cm or less | 21 | $4,063 | $68 |
| Short return visit | 83 | $3,807 | $38 |
| Trimming of fingernails or toenails | 185 | $3,697 | $9 |
| Removal of inflamed or infected skin, up to 10% of body surface | 26 | $1,702 | $47 |
| Simple or single drainage of skin abscess | 15 | $1,609 | $101 |
| X-ray of foot, minimum of 3 views | 43 | $1,539 | $29 |
| Removal of noncancer thickened skin growth, more than 4 growths | 20 | $1,505 | $44 |
| New patient visit (15+ min) | 24 | $1,412 | $59 |
| Injection into tendon or ligament | 18 | $1,042 | $47 |
| X-ray of foot, 2 views | 14 | $419 | $25 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 20 | $112 | None |
2013: 16 services
| Removal of fingernails or toenails, 1-5 nails | 288 | $17,293 | $28 |
| Removal of noncancer thickened skin growth, 2-4 growths | 156 | $12,123 | $39 |
| New patient visit (30+ min) | 97 | $8,809 | $91 |
| Removal of tissue from wound, 20.0 sq cm or less | 33 | $8,537 | $69 |
| Short return visit (20+ min) | 95 | $7,361 | $50 |
| Short return visit | 119 | $6,289 | $38 |
| Trimming of fingernails or toenails | 216 | $3,730 | $7 |
| Removal of noncancer thickened skin growth, more than 4 growths | 27 | $1,988 | $47 |
| Injection into tendon or ligament | 27 | $1,819 | $47 |
| Removal of inflamed or infected skin, up to 10% of body surface | 22 | $1,579 | $46 |
| New patient visit (15+ min) | 22 | $1,407 | $64 |
| X-ray of foot, minimum of 3 views | 29 | $1,243 | $29 |
| X-ray of foot, 2 views | 22 | $756 | $25 |
| Removal of fingernails or toenails, 6 or more nails | 14 | $693 | $38 |
| Removal of noncancer thickened skin growth, 1 growth | 16 | $613 | $36 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 30 | $187 | None |
Medicaid work
$10,106 in 2024
Medicaid paid $10,106 for 835 billed services this clinician did in 2024, up to 79 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 657 | $5,854 |
| New patient visit (45+ min) | 152 | $4,096 |
| Debridement of nail(s) by any method(s); 1 to 5 | 12 | $79 |
| Debridement of extensive eczematous or infected skin; up to 10% of body surface | 14 | $77 |
| 2024 | 835 | 4 | 79 | $10,106 |
| 2023 | 1,212 | 3 | 62 | $26,518 |
| 2022 | 963 | 3 | 56 | $23,379 |
| 2021 | 846 | 2 | 60 | $21,394 |
| 2020 | 1,019 | 2 | 73 | $28,831 |
| 2019 | 899 | 4 | 86 | $28,560 |
| 2018 | 286 | 2 | 32 | $4,756 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 1,023 | $20,241 |
| New patient visit (45+ min) | 150 | $5,840 |
| Debridement of nail(s) by any method(s); 1 to 5 | 39 | $437 |
2022
| Short return visit (20+ min) | 868 | $19,343 |
| New patient visit (45+ min) | 83 | $3,875 |
| Debridement of nail(s) by any method(s); 1 to 5 | 12 | $162 |
2021
| Short return visit (20+ min) | 765 | $17,363 |
| New patient visit (45+ min) | 81 | $4,030 |
2020
| Short return visit (20+ min) | 877 | $22,199 |
| New patient visit (45+ min) | 142 | $6,633 |
2019
| Short return visit (20+ min) | 680 | $18,438 |
| New patient visit (45+ min) | 190 | $9,109 |
| New patient visit (30+ min) | 16 | $582 |
| X-RAY EXAM OF FOOT | 13 | $431 |
2018
| Short return visit (20+ min) | 257 | $4,717 |
| Debridement of nail(s) by any method(s); 1 to 5 | 29 | $39 |
Drugs they prescribed that Part D paid
$52,563
Pharmacies billed $52,563 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,058 generic and fewer than 11 brand-name prescriptions · $52,563 in drug cost · 130 antibiotic prescriptions to 68 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Naftifine | 26 | $9,625 | $370 |
| Lidocaine | 86 | $7,266 | $84 |
| Mupirocin | 31 | $7,102 | $229 |
| Ketoconazole | 201 | $6,370 | $32 |
| Diclofenac | 117 | $3,859 | $33 |
See all 17 drugs
| Naftifine | 26 | $9,625 | $370 |
| Lidocaine | 86 | $7,266 | $84 |
| Mupirocin | 31 | $7,102 | $229 |
| Ketoconazole | 201 | $6,370 | $32 |
| Diclofenac | 117 | $3,859 | $33 |
| Ammonium Lactate | 142 | $2,567 | $18 |
| Econazole Nitrate | 33 | $2,190 | $66 |
| Mupirocin | 145 | $843 | $6 |
| Fluocinonide | 16 | $703 | $44 |
| Cephalexin | 47 | $268 | $6 |
| Amoxicillin-Clavulanate Potass | 30 | $236 | $8 |
| Terbinafine | 22 | $224 | $10 |
| Ibuprofen | 31 | $209 | $7 |
| Gabapentin | 24 | $147 | $6 |
| Ssd | 11 | $126 | $11 |
| Doxycycline Hyclate | 19 | $110 | $6 |
| Levofloxacin | 19 | $51 | $3 |
Year by year
| 2024 | 1,091 | 356 | None | None | $52,563 |
| 2023 | 1,158 | 380 | None | 5% | $71,957 |
| 2022 | 1,044 | 387 | 1% (14) | 7% | $74,253 |
| 2021 | 1,015 | 349 | 1% (13) | 5% | $79,290 |
| 2020 | 1,327 | 398 | None | 8% | $145,701 |
| 2019 | 1,185 | 416 | 2% (20) | 10% | $122,866 |
| 2018 | 1,201 | 422 | 5% (56) | 12% | $96,233 |
| 2017 | 1,018 | 360 | 5% (49) | None | $84,486 |
| 2016 | 1,212 | 432 | 4% (53) | None | $108,675 |
| 2015 | 1,148 | 404 | 6% (71) | None | $113,967 |
| 2014 | 964 | 386 | 10% (98) | None | $42,770 |
| 2013 | 956 | 381 | 9% (85) | 18% | $32,842 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Mupirocin | 47 | $14,876 | $317 |
| Lidocaine | 99 | $13,520 | $137 |
| Ketoconazole | 192 | $8,230 | $43 |
| Santyl | 21 | $6,484 | $309 |
| Naftifine | 19 | $5,724 | $301 |
| Ammonium Lactate | 154 | $3,624 | $24 |
| Diclofenac | 148 | $3,593 | $24 |
| Econazole Nitrate | 34 | $2,980 | $88 |
| Fluocinonide | 21 | $1,357 | $65 |
| Mupirocin | 149 | $1,026 | $7 |
| Cephalexin | 56 | $425 | $8 |
| Amoxicillin-Clavulanate Potass | 30 | $247 | $8 |
| Doxycycline Hyclate | 19 | $240 | $13 |
| Levofloxacin | 25 | $213 | $9 |
| Gabapentin | 32 | $180 | $6 |
| Ibuprofen | 14 | $114 | $8 |
| Terbinafine | 11 | $98 | $9 |
| Ssd | 13 | $86 | $7 |
| Silver Sulfadiazine | 11 | $68 | $6 |
2022: 16 drugs
| Lidocaine | 97 | $13,719 | $141 |
| Ketoconazole | 181 | $13,516 | $75 |
| Mupirocin | 20 | $8,266 | $413 |
| Santyl | 22 | $6,205 | $282 |
| Diclofenac | 188 | $4,514 | $24 |
| Econazole Nitrate | 27 | $4,117 | $152 |
| Ammonium Lactate | 134 | $3,148 | $23 |
| Mupirocin | 125 | $1,179 | $9 |
| Amoxicillin-Clavulanate Potass | 42 | $488 | $12 |
| Lidocaine-Prilocaine | 14 | $312 | $22 |
| Doxycycline Hyclate | 13 | $176 | $14 |
| Terbinafine | 15 | $171 | $11 |
| Ssd | 19 | $152 | $8 |
| Cephalexin | 22 | $150 | $7 |
| Gabapentin | 22 | $134 | $6 |
| Silver Sulfadiazine | 12 | $114 | $10 |
2021: 16 drugs
| Lidocaine | 130 | $20,799 | $160 |
| Ketoconazole | 149 | $10,246 | $69 |
| Econazole Nitrate | 43 | $8,837 | $206 |
| Mupirocin | 23 | $6,832 | $297 |
| Ammonium Lactate | 162 | $3,818 | $24 |
| Santyl | 13 | $3,468 | $267 |
| Diclofenac | 101 | $3,297 | $33 |
| Mupirocin | 137 | $1,321 | $10 |
| Amoxicillin-Clavulanate Potass | 32 | $617 | $19 |
| Doxycycline Hyclate | 26 | $518 | $20 |
| Lidocaine-Prilocaine | 15 | $413 | $28 |
| Cephalexin | 38 | $216 | $6 |
| Gabapentin | 18 | $153 | $9 |
| Terbinafine | 12 | $102 | $9 |
| Levofloxacin | 14 | $73 | $5 |
| Sodium Chloride | 14 | $54 | $4 |
2020: 21 drugs
| Lidocaine | 214 | $41,984 | $196 |
| Regranex | 15 | $19,223 | $1,282 |
| Ketoconazole | 197 | $15,616 | $79 |
| Econazole Nitrate | 73 | $13,752 | $188 |
| Oxiconazole Nitrate | 19 | $11,901 | $626 |
| Santyl | 30 | $8,310 | $277 |
| Naftifine | 29 | $7,878 | $272 |
| Mupirocin | 14 | $4,505 | $322 |
| Ammonium Lactate | 130 | $2,856 | $22 |
| Lidocaine-Prilocaine | 45 | $2,229 | $50 |
| Mupirocin | 164 | $1,663 | $10 |
| Diclofenac | 52 | $1,610 | $31 |
| Fluocinonide | 24 | $1,258 | $52 |
| Amoxicillin-Clavulanate Potass | 33 | $537 | $16 |
| Cephalexin | 61 | $502 | $8 |
| Gabapentin | 48 | $407 | $8 |
| Doxycycline Hyclate | 18 | $326 | $18 |
| Levofloxacin | 12 | $199 | $17 |
| Ibuprofen | 22 | $171 | $8 |
| Terbinafine | 18 | $130 | $7 |
| Sodium Chloride | 36 | $130 | $4 |
2019: 18 drugs
| Lidocaine | 178 | $32,332 | $182 |
| Ketoconazole | 186 | $16,589 | $89 |
| Santyl | 43 | $13,264 | $308 |
| Diclofenac | 61 | $13,189 | $216 |
| Econazole Nitrate | 33 | $9,425 | $286 |
| Naftifine | 16 | $5,277 | $330 |
| Ammonium Lactate | 133 | $2,902 | $22 |
| Lidocaine-Prilocaine | 48 | $2,442 | $51 |
| Mupirocin | 147 | $1,721 | $12 |
| Doxycycline Hyclate | 35 | $1,046 | $30 |
| Voltaren | 16 | $822 | $51 |
| Amoxicillin-Clavulanate Potass | 49 | $665 | $14 |
| Cephalexin | 48 | $398 | $8 |
| Levofloxacin | 25 | $233 | $9 |
| Gabapentin | 23 | $155 | $7 |
| Ibuprofen | 13 | $142 | $11 |
| Sodium Chloride | 23 | $98 | $4 |
| Hydrocodone-Acetaminophen | 16 | $80 | $5 |
2018: 19 drugs
| Lidocaine | 160 | $21,128 | $132 |
| Mupirocin | 37 | $18,242 | $493 |
| Ketoconazole | 186 | $17,336 | $93 |
| Santyl | 37 | $10,168 | $275 |
| Econazole Nitrate | 41 | $6,132 | $150 |
| Ammonium Lactate | 161 | $3,768 | $23 |
| Voltaren | 37 | $2,228 | $60 |
| Mupirocin | 151 | $1,791 | $12 |
| Diclofenac | 35 | $1,206 | $34 |
| Amoxicillin-Clavulanate Potass | 70 | $1,049 | $15 |
| Lidocaine-Prilocaine | 15 | $591 | $39 |
| Hydrocodone-Acetaminophen | 52 | $492 | $9 |
| Doxycycline Hyclate | 13 | $427 | $33 |
| Clindamycin | 15 | $262 | $17 |
| Levofloxacin | 17 | $188 | $11 |
| Gabapentin | 26 | $179 | $7 |
| Cephalexin | 20 | $168 | $8 |
| Naproxen | 12 | $94 | $8 |
| Sodium Chloride | 22 | $80 | $4 |
2017: 17 drugs
| Econazole Nitrate | 103 | $17,815 | $173 |
| Lidocaine | 84 | $17,599 | $210 |
| Santyl | 50 | $17,073 | $341 |
| Ammonium Lactate | 172 | $4,329 | $25 |
| Ketoconazole | 57 | $3,779 | $66 |
| Amoxicillin-Clavulanate Potass | 86 | $1,407 | $16 |
| Mupirocin | 109 | $962 | $9 |
| Doxycycline Hyclate | 19 | $646 | $34 |
| Gabapentin | 53 | $498 | $9 |
| Hydrocodone-Acetaminophen | 41 | $347 | $8 |
| Ciprofloxacin | 24 | $326 | $14 |
| Clindamycin | 12 | $196 | $16 |
| Sodium Chloride | 48 | $184 | $4 |
| Terbinafine | 18 | $173 | $10 |
| Cephalexin | 18 | $156 | $9 |
| Silver Sulfadiazine | 12 | $129 | $11 |
| Meloxicam | 12 | $55 | $5 |
2016: 18 drugs
| Lidocaine | 186 | $33,000 | $177 |
| Econazole Nitrate | 142 | $27,987 | $197 |
| Regranex | 19 | $18,211 | $958 |
| Santyl | 40 | $8,296 | $207 |
| Ammonium Lactate | 137 | $3,320 | $24 |
| Amoxicillin-Clavulanate Potass | 123 | $2,061 | $17 |
| Mupirocin | 149 | $1,311 | $9 |
| Ketoconazole | 12 | $1,006 | $84 |
| Doxycycline Hyclate | 30 | $941 | $31 |
| Hydrocodone-Acetaminophen | 51 | $604 | $12 |
| Sodium Chloride | 75 | $478 | $6 |
| Gabapentin | 35 | $375 | $11 |
| Lidocaine | 20 | $340 | $17 |
| Silver Sulfadiazine | 24 | $285 | $12 |
| Ciprofloxacin | 20 | $255 | $13 |
| Terbinafine | 29 | $225 | $8 |
| Cephalexin | 17 | $112 | $7 |
| Meloxicam | 13 | $38 | $3 |
2015: 18 drugs
| Econazole Nitrate | 187 | $44,223 | $236 |
| Lidocaine | 150 | $24,329 | $162 |
| Regranex | 11 | $11,118 | $1,011 |
| Naftin | 22 | $10,536 | $479 |
| Santyl | 40 | $8,529 | $213 |
| Clobetasol Propionate | 15 | $3,059 | $204 |
| Ammonium Lactate | 132 | $2,679 | $20 |
| Amoxicillin-Clavulanate Potass | 84 | $1,403 | $17 |
| Mupirocin | 139 | $1,311 | $9 |
| Doxycycline Hyclate | 21 | $1,084 | $52 |
| Hydrocodone-Acetaminophen | 65 | $781 | $12 |
| Levofloxacin | 35 | $459 | $13 |
| Silver Sulfadiazine | 23 | $274 | $12 |
| Cephalexin | 27 | $243 | $9 |
| Sodium Chloride | 60 | $230 | $4 |
| Gabapentin | 23 | $221 | $10 |
| Sulfamethoxazole-Trimethoprim | 11 | $74 | $7 |
| Meloxicam | 16 | $68 | $4 |
2014: 15 drugs
| Econazole Nitrate | 166 | $12,081 | $73 |
| Naftin | 14 | $6,897 | $493 |
| Lidocaine | 41 | $3,588 | $88 |
| Santyl | 19 | $3,538 | $186 |
| Clobetasol Propionate | 26 | $2,639 | $102 |
| Amox Tr-Potassium Clavulanate | 120 | $2,638 | $22 |
| Ammonium Lactate | 96 | $2,265 | $24 |
| Mupirocin | 128 | $1,514 | $12 |
| Hydrocodone-Acetaminophen | 87 | $1,327 | $15 |
| Cephalexin | 24 | $296 | $12 |
| Sodium Chloride | 61 | $233 | $4 |
| Ciprofloxacin | 17 | $176 | $10 |
| Sulfamethoxazole-Trimethoprim | 25 | $144 | $6 |
| Silver Sulfadiazine | 14 | $133 | $9 |
| Gabapentin | 13 | $123 | $9 |
2013: 16 drugs
| Econazole Nitrate | 166 | $4,317 | $26 |
| Naftin | 14 | $4,106 | $293 |
| Santyl | 22 | $4,004 | $182 |
| Amox Tr-Potassium Clavulanate | 111 | $2,906 | $26 |
| Doxycycline Hyclate | 40 | $2,673 | $67 |
| Ammonium Lactate | 106 | $2,166 | $20 |
| Lidocaine | 25 | $2,030 | $81 |
| Mupirocin | 102 | $1,473 | $14 |
| Urea | 22 | $662 | $30 |
| Hydrocodone-Acetaminophen | 77 | $633 | $8 |
| Sodium Chloride | 62 | $293 | $5 |
| Cephalexin | 30 | $272 | $9 |
| Silver Sulfadiazine | 24 | $246 | $10 |
| Clobetasol Propionate | 11 | $202 | $18 |
| Clindamycin | 14 | $174 | $12 |
| Sulfamethoxazole-Trimethoprim | 12 | $97 | $8 |
Money from drug and device companies
$186 in 2025
| 2025 | 3 | 4 | None | $186 |
| 2024 | 4 | 6 | None | $203 |
| 2023 | 5 | 7 | None | $131 |
| 2022 | 10 | 24 | None | $1,010 |
| 2021 | 7 | 12 | None | $533 |
| 2020 | 4 | 17 | None | $342 |
| 2019 | 8 | 30 | None | $829 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AngioDynamics | Auryon Laser System 100-120 Vac | $125 | 1 payment
|
| Smith+Nephew | Collagenase Santyl | $43 | 2 payments
|
| Bioventus | Exogen Ultrasound Bone Healing System | $18 | 1 payment
|
See all 4 published payments
| AngioDynamics | Meals · 2025-06-04 | Auryon Laser System 100-120 Vac | $125 |
| Smith+Nephew | Meals · 2025-03-12 | Collagenase Santyl | $23 |
| Bioventus | Meals · 2025-02-11 | Exogen Ultrasound Bone Healing System | $18 |
| Smith+Nephew | Meals · 2025-01-03 | Collagenase Santyl | $19 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $203
| Amgen | Krystexxa | $122 | 1 payment
|
| Smith+Nephew | Collagenase Santyl | $50 | 3 payments
|
| Djo | Procare | $18 | 1 payment
|
| Abbvie | Dalvance | $14 | 1 payment
|
2023: $131
| Smith+Nephew | Collagenase Santyl | $51 | 3 payments
|
| Horizon Therapeutics plc | Krystexxa | $29 | 1 payment
|
| Djo | Aircast | $20 | 1 payment
|
| Kci USA | Activ.A.C. | $17 | 1 payment
|
| Sebela Pharmaceuticals | Naftin | $14 | 1 payment
|
2022: $1,010
| AngioDynamics | Auryon Laser System 100-120 Vac | $421 | 5 payments
|
| Smith+Nephew | Collagenase Santyl | $147 | 11 payments
|
| Amgen | Otezla | $125 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $118 | 1 payment
|
| Cardiovascular Systems | None | $82 | 1 payment
|
| Bioventus | Exogen Ultrasound Bone Healing System | $40 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $25 | 1 payment
|
| Sebela Pharmaceuticals | Naftin | $19 | 1 payment
|
| Nabriva Therapeutics plc | Sivextro | $17 | 1 payment
|
| Abbvie | Dalvance | $15 | 1 payment
|
2021: $533
| Cardiovascular Systems | Diamondback Peripheral | $225 | 2 payments
|
| AngioDynamics | Auryon Laser System 100-120 Vac | $153 | 1 payment
|
| Smith+Nephew | Collagenase Santyl | $79 | 4 payments
|
| Paratek Pharmaceuticals | Nuzyra | $23 | 1 payment
|
| Nabriva Therapeutics plc | Sivextro | $21 | 1 payment
|
| Sebela Pharmaceuticals | Pramosone | $19 | 1 payment
|
| AbbVie | Dalvance | $15 | 1 payment
|
2020: $342
| Smith+Nephew | Santyl | $236 | 14 payments
|
| Cardiovascular Systems | Peripheral Orbital Atherectomy System | $76 | 1 payment
|
| Bioventus | Exogen | $17 | 1 payment
|
| Kci USA | Snap | $14 | 1 payment
|
2019: $829
| Melinta Therapeutics | Orbactiv | $209 | 5 payments
|
| Smith+Nephew | Santyl | $163 | 18 payments
|
| Bioventus | Exogen | $141 | 1 payment
|
| Amgen | Enbrel | $125 | 1 payment
|
| AbbVie | None | $125 | 1 payment
|
| Horizon Therapeutics plc | Rayos | $27 | 2 payments
|
| Djo | Cmf Ol1000 | $20 | 1 payment
|
| Paragon 28 | None | $19 | 1 payment
|
Professional record
- NPI
- 1437170982
- Licence
- CA E1549
- Trained
- New York College of Podiatric Medicine, 1972 · 54 years ago
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 213E00000X (213E00000X)
- Mailing address
- 1135 S Sunset Ave Ste 107, West Covina, CA, 91790
- NPI first listed
- 2006-07-21
- NPI last updated
- 2008-01-30
This is when the NPI record was last certified, not a medical board exam.